FFA
SANA icon

Farther Finance Advisors’s Sana Biotechnology SANA Stock Holding History

Farther Finance Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.55K Buy
2,590
+100
+4% +$348 ﹤0.01% 4790
2026
Q2 		$8.69K Hold
2,490
– – ﹤0.01% 4516
2026
Q1 		$7.59K Sell
2,490
-1
-0% -$4 ﹤0.01% 4284
2025
Q4 		$10.1K Buy
2,491
+491
+25% +$2.2K ﹤0.01% 3897
2025
Q3 		$7.1K Sell
2,000
-3,064
-61% -$11.1K ﹤0.01% 3602
2025
Q2 		$13.8K Sell
5,064
-7,291
-59% -$15K ﹤0.01% 2898
2025
Q1 		$18.5K Buy
+12,355
New +$34.5K ﹤0.01% 2423
2024
Q4 		– Sell
-14
Closed -$58 – 4129
2024
Q3 		$58 Hold
14
– – ﹤0.01% 3854
2024
Q2 		$77 Hold
14
– – ﹤0.01% 3631
2024
Q1 		$142 Hold
14
– – ﹤0.01% 3326
2023
Q4 		$57 Buy
+14
New +$52 ﹤0.01% 3362

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's SANA Position: Q3 2026 in Review

Farther Finance Advisors increased its Sana Biotechnology (SANA) stake by 4% in Q3 2026, buying an estimated $348 and bringing the position to 2,590 shares worth $7.55K. The position accounts for ﹤0.01% of the portfolio, ranked #4790.

Farther Finance Advisors first reported a position in SANA in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.5K in Q1 2025. 6 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Farther Finance Advisors held 2,590 shares of Sana Biotechnology worth $7.55K as of Q3 2026.
  • Farther Finance Advisors bought 100 Sana Biotechnology shares in Q3 2026, an estimated $348.
  • Sana Biotechnology made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4790 holding.
  • Farther Finance Advisors first reported a position in Sana Biotechnology in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Sana Biotechnology position peaked at $18.5K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.